J. Ha

Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

C. Larsen, E. Elwood, T. Pearson, 1999, The Journal of clinical investigation.

Role of the IL-33/ST2 pathway in renal allograft rejection.

K. Moon, G. Kim, Yong-Chul Kim, 2021, Experimental cell research.

Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning1

C. Larsen, T. Pearson, A. Bingaman, 2000, The Journal of Immunology.

Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts1

C. Larsen, T. Pearson, J. Trambley, 2000, The Journal of Immunology.

Costimulation Blockade-resistant Rejection the Role of the Il-2 Pathway In

C. Larsen, T. Pearson, J. Ha, 2022 .

The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts1

C. Larsen, T. Pearson, J. Ha, 2002, The Journal of Immunology.

Conventional Immunosuppression is Compatible with Costimulation Blockade‐Based, Mixed Chimerism Tolerance Induction

Zhong Guo, C. Larsen, T. Pearson, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression1

C. Larsen, T. Pearson, A. Bingaman, 2001, The Journal of Immunology.

Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses.

C. Larsen, R. Hendrix, C. Tucker-Burden, 2000, Transplantation.

Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.

C. Larsen, T. Pearson, A. Bingaman, 2001, Transplant immunology.

of Danger Vigorous Allograft Rejection in the Absence

C. Larsen, R. Hendrix, C. Tucker-Burden, 2000 .

Genetic interactions between the donor and the recipient for susceptibility to AR

Hyosang Kim, Y. Kim, J. Ha, 2009 .

Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.

C. Larsen, C. Tucker-Burden, T. Pearson, 2001, Transplantation.

Vigorous Allograft Rejection in the Absence of Danger1

C. Larsen, R. Hendrix, C. Tucker-Burden, 2000, The Journal of Immunology.